Tumor Cell Biology and Gene Therapy
The ultimate solution to the problem of breast cancer resides in understanding fundamental processes causing tumorogenesis and development of the malignant phenotype. Breast cancer is unique due to its strong endocrine responsiveness with the estrogen receptor an integral part of cellular signaling leading to unrestrained growth.

Overview of Developments in First and Second-line Treatment Strategies of Metastatic Breast Cancer
The 2002 San Antonio Breast Cancer Symposium highlighted a number of presentations which focused on evaluating treatment strategies for first and second-line therapy of metastatic disease, as well as helped to define the optimal regimens to be in the neoadjuvant setting.

Adjuvant and Neoadjuvant Therapy in Breast Cancer-Where are we going?
In 2003, over 200,000 American women will be diagnosed with invasive breast cancer. The Oxford overview has defined the benefit of adjuvant hormonal treatment and chemotherapy.